BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 498973)

  • 1. [Massive obesity with disturbance of glucose tolerance (author's transl)].
    Toeller M; Gries FA; Shleppinghoff B; Berger M; Dannehl K
    Dtsch Med Wochenschr; 1979 Oct; 104(43):1513-7. PubMed ID: 498973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Weight reduction and glucose intolerance in obese subjects (author's transl)].
    Berger M; Baumhoff E; Gries FA
    Dtsch Med Wochenschr; 1976 Feb; 101(9):307-11. PubMed ID: 1248416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Weight reduction and sugar deprivation in glucose tolerance disturbance. A two-year study of 131 normal and overweight subjects (author's transl)].
    Schimmler W; Schuderer A; Kurz M
    MMW Munch Med Wochenschr; 1976 Nov; 118(46):1481-4. PubMed ID: 825766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oral glucose tolerance tests--with or without estimation of serum insulin? (author's transl)].
    Haupt E; Petzoldt R; Probst S; Schöffling K
    Dtsch Med Wochenschr; 1981 Jun; 106(25):798-803. PubMed ID: 7016491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on the incidence of diabetes mellitus in obese patients].
    Drobny H; Schneyer U
    Z Gesamte Inn Med; 1982 Jul; 37(14):453-8. PubMed ID: 7136089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term study of glucose tolerance in individuals with a suspected diagnosis of diabetes].
    Kmoch J; Kabrhelová A; Kmoch J; Hradec J
    Vnitr Lek; 1993 Jun; 39(6):564-8. PubMed ID: 8212611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The provoked-hyperglycemia test. Follow-up after two years of 94 cases with doubtful results (author's transl)].
    Lubetzki J; Duprey J; Guillausseau PJ; Guillausseau C; Warnet A; Malbec D
    Ann Med Interne (Paris); 1979; 130(3):191-5. PubMed ID: 434732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["Diabetic" proliferative retinopathy and nodular glomerulosclerosis without diabetes mellitus].
    Biesenbach G; Hommer K; Stadler G; Kramar R; Syré G; Zazgornik J
    Dtsch Med Wochenschr; 1988 Dec; 113(50):1968-71. PubMed ID: 3197624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal dlabetes and chemical diabetes. Course in young subjects with normal weight (author's transl)].
    Schrub JC; Courtois H; Vuillermet P
    Nouv Presse Med; 1978 Jun; 7(24):2145-7. PubMed ID: 683861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution to the early diagnosis of diabetes mellitus.
    Băcanu G; Anghelescu L; Serban V; Vărădeanu A; Negrişanu G; Tudor C
    Med Interne; 1986; 24(1):3-10. PubMed ID: 3704502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus.
    Watts NB; Spanheimer RG; DiGirolamo M; Gebhart SS; Musey VC; Siddiq YK; Phillips LS
    Arch Intern Med; 1990 Apr; 150(4):803-6. PubMed ID: 2327840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The insulin level in the glucose tolerance test in patients with obesity and varying carbohydrate tolerance (author's transl)].
    Graczykowska-Koczorowska A; Ponikowska I; Bruszyńska B; Tycowa M; Kosowicz J; Porawska J
    Przegl Lek; 1980; 37(2):301-4. PubMed ID: 6988899
    [No Abstract]   [Full Text] [Related]  

  • 16. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Present day problems in the diagnosis of diabetes (author's transl)].
    Knick J; Knick B; Thomas L; Hinze H
    MMW Munch Med Wochenschr; 1979 Dec; 121(49):1645-8. PubMed ID: 118365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of patients with abnormal glucose challenge test and normal oral glucose tolerance test results: comparison with normal and gestational diabetic patients.
    Dudhbhai M; Lim L; Bombard A; Juliard K; Meenakshi B; Trachelenberg Y; Weiner Z
    Am J Obstet Gynecol; 2006 May; 194(5):e42-5. PubMed ID: 16647897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.